Ureidopropionase, beta (UPB1) Peptide
UPB1
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all UPB1 products
- UPB1 (Ureidopropionase, beta (UPB1))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- AVVISNSGAV LGKTRKNHIP RVGDFNESTY YMEGNLGHPV FQTQFGRIAV
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of UPB1 antibody,
Alternative Names: UPB1 control peptide, UPB1 antibody Blocking Peptide, Anti-UPB1 Blocking Peptide, Ureidopropionase Beta Blocking Peptide, BUP1 Blocking Peptide, UPB1, UPB-1, UPB 1, UPB-1 Blocking Peptide, UPB 1 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- UPB1 (Ureidopropionase, beta (UPB1))
- Background
- UPB1 is a protein that belongs to the CN hydrolase family. Beta-ureidopropionase catalyzes the last step in the pyrimidine degradation pathway. The pyrimidine bases uracil and thymine are degraded via the consecutive action of dihydropyrimidine dehydrogenase (DHPDH), dihydropyrimidinase (DHP) and beta-ureidopropionase (UP) to beta-alanine and beta-aminoisobutyric acid, respectively. UP deficiencies are associated with N-carbamyl-beta-amino aciduria and may lead to abnormalities in neurological activity.
- Molecular Weight
- 42 kDa
-
You are here:
